Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under 60 DEGREES PHARMACEUTICALS, INC. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Eric Francois, Director (Form 8-K filed 2026-05-18). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Lind Global Fund Iii LP (filed 2026-08-05).
Who is behind it
60 DEGREES PHARMACEUTICALS, INC.: incorporated in Delaware; business address in Washington, District of Columbia; industry Pharmaceutical Preparations (Schedule 13G, 2026-08-05).
Officers and directors, each with the role and the filing that names them:
- Geoffrey S. Dow: Executive Officer, Director (Form D, 2025-02-12)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-05 | Lind Global Fund Iii LP | 5.45% |
| Schedule 13G, 2026-07-29 | Knight Therapeutics Inc. | 19.85% |
| Schedule 13G/A, 2026-05-15 | Knight Therapeutics Inc. | 0% |
| Schedule 13G/A, 2026-05-15 | Cvi Investments, Inc. | 7% |
| Schedule 13G/A, 2026-05-13 | Mitchell P. Kopin | 9.1% |
| Schedule 13G/A, 2025-11-13 | Ayrton Capital LLC | 4.14% |
| Schedule 13G/A, 2025-11-07 | Cvi Investments, Inc. | 9.9% |
| Schedule 13G/A, 2025-11-07 | Mitchell P. Kopin | 9.99% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-05-18 | Eric Francois | Director | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-02-12 | $1.08M | $1.08M |
| Form D, 2025-02-11 | $1.04M | $1.04M |
| Form D, 2023-05-24 | $1.75M | not stated |
Latest IPO step: 60 DEGREES PHARMACEUTICALS, INC. filed its final IPO prospectus, ticker SXTP (424B4, 2025-07-16).
IPO filings: 424B4, 2025-07-16, S-1, 2025-07-07, S-1/A, 2025-03-27, S-1, 2025-02-14; ticker SXTP on Nasdaq Capital Market.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/60-degrees-pharmaceuticalsLast updated 2026-10-18
Primary record: Schedule 13G, 2026-08-05 · Form D, 2025-02-12 · Form 8-K, 2026-05-18 · 424B4, 2025-07-16
Who owns 60 DEGREES PHARMACEUTICALS, INC.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/60-degrees-pharmaceuticals